OCTOBER 2020: FALL UPDATE
As a result of the successful financing round of CHF 10 million in April 2020, the InnoMedica team was able to reach important milestones in the main projects Talidox and Talineuren in the last months and make progress in the…
April 2020: Capital increase with public offering
Please find below the relevant investor documents (including subscription form). Information on InnoMedica and the projects TaliCoVax-19 (vaccination), Talidox (oncology) and Talineuren (neurology) can be found in the business documentation. Investor Documentation Download Business Documentation 2020 Download last year’s…
March 2020: InnoMedica launches project for corona vaccination
The corona pandemic is a major challenge for everyone. In this context, InnoMedica can contribute its expertise to the development of an urgently needed vaccine. InnoMedica has good contacts with the Institute for Virology and Immunology IVI in Mittelhäusern, BE…
